← All trials
NCT06512519
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2024
- Primary completion
- Jun 30, 2026
- Completion date
- Jun 30, 2027
- First posted
- Jul 22, 2024
- Last posted
- Nov 7, 2024
- Enrollment
- 34
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Peking UniversityLead sponsor
- Guangdong Provincial Hospital of Traditional Chinese MedicineCollaborator
- Southern Medical UniversityCollaborator
- Zhengzhou UniversityCollaborator
- Fujian Medical UniversityCollaborator
- Shengjing HospitalCollaborator
- Peking UniversitySponsor investigator
- Jiao Tong UniversityCollaborator
- Soochow UniversityCollaborator
- Zhejiang UniversityCollaborator
- Xinjiang Medical UniversityCollaborator
- Hacettepe UniversityCollaborator
- Peking UniversityOfficial
- Huazhong University of Science and TechnologyCollaborator
- Anhui Medical UniversityCollaborator
- Nanjing Medical UniversityCollaborator
- Peking UniversityCollaborator
- Shandong Provincial HospitalCollaborator
- People's Liberation Army of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.